Annual total expenses:
$2.41B+$160.58M(+7.13%)Summary
- As of today (September 13, 2025), BMRN annual total expenses is $2.41 billion, with the most recent change of +$160.58 million (+7.13%) on December 31, 2024.
- During the last 3 years, BMRN annual total expenses has risen by +$502.19 million (+26.29%).
- BMRN annual total expenses is now at all-time high.
Performance
BMRN Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$586.94M+$40.03M(+7.32%)Summary
- As of today (September 13, 2025), BMRN quarterly total expenses is $586.94 million, with the most recent change of +$40.03 million (+7.32%) on June 30, 2025.
- Over the past year, BMRN quarterly total expenses has dropped by -$14.54 million (-2.42%).
- BMRN quarterly total expenses is now -18.45% below its all-time high of $719.73 million, reached on June 30, 2016.
Performance
BMRN Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
BMRN Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.1% | -2.4% |
| 3 y3 years | +26.3% | +17.3% |
| 5 y5 years | +41.0% | +30.3% |
BMRN Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +26.6% | -7.8% | +18.2% |
| 5 y | 5-year | at high | +145.3% | -7.8% | +288.9% |
| alltime | all time | at high | >+9999.0% | -18.4% | +288.9% |
BMRN Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $586.94M(+7.3%) |
| Mar 2025 | - | $546.91M(-10.8%) |
| Dec 2024 | $2.41B(+7.1%) | $613.28M(-3.6%) |
| Sep 2024 | - | $636.29M(+5.8%) |
| Jun 2024 | - | $601.48M(+7.2%) |
| Mar 2024 | - | $561.29M(-10.3%) |
| Dec 2023 | $2.25B(+18.1%) | $625.53M(+14.7%) |
| Sep 2023 | - | $545.59M(+1.3%) |
| Jun 2023 | - | $538.56M(-0.7%) |
| Mar 2023 | - | $542.09M(+5.1%) |
| Dec 2022 | $1.91B(-0.2%) | $516.02M(+3.9%) |
| Sep 2022 | - | $496.72M(-0.7%) |
| Jun 2022 | - | $500.21M(+27.3%) |
| Mar 2022 | - | $392.99M(-21.8%) |
| Dec 2021 | $1.91B(+94.3%) | $502.48M(+13.0%) |
| Sep 2021 | - | $444.83M(-9.5%) |
| Jun 2021 | - | $491.43M(+4.2%) |
| Mar 2021 | - | $471.42M(+9.8%) |
| Dec 2020 | $983.23M(-42.5%) | $429.20M(-238.1%) |
| Sep 2020 | - | -$310.71M(-169.0%) |
| Jun 2020 | - | $450.39M(+8.7%) |
| Mar 2020 | - | $414.36M(-4.3%) |
| Dec 2019 | $1.71B(+8.6%) | $432.92M(+8.3%) |
| Sep 2019 | - | $399.87M(-5.0%) |
| Jun 2019 | - | $420.92M(-7.8%) |
| Mar 2019 | - | $456.52M(+28.2%) |
| Dec 2018 | $1.57B(+9.6%) | $356.19M(-10.8%) |
| Sep 2018 | - | $399.30M(+1.4%) |
| Jun 2018 | - | $393.70M(-7.4%) |
| Mar 2018 | - | $425.24M(+2.4%) |
| Dec 2017 | $1.44B(-17.5%) | $415.09M(+18.2%) |
| Sep 2017 | - | $351.32M(-0.5%) |
| Jun 2017 | - | $353.16M(+11.6%) |
| Mar 2017 | - | $316.49M(-19.0%) |
| Dec 2016 | $1.74B(+66.8%) | $390.81M(+23.7%) |
| Sep 2016 | - | $315.88M(-56.1%) |
| Jun 2016 | - | $719.73M(+127.3%) |
| Mar 2016 | - | $316.60M(+98.7%) |
| Dec 2015 | $1.04B(+18.1%) | $159.32M(-46.1%) |
| Sep 2015 | - | $295.42M(-9.9%) |
| Jun 2015 | - | $328.00M(+23.3%) |
| Mar 2015 | - | $266.03M(-11.5%) |
| Dec 2014 | $884.00M(+22.0%) | $300.65M(+78.1%) |
| Sep 2014 | - | $168.84M(-25.3%) |
| Jun 2014 | - | $226.00M(+19.4%) |
| Mar 2014 | - | $189.35M(-9.7%) |
| Dec 2013 | $724.80M(+19.0%) | $209.75M(+10.6%) |
| Sep 2013 | - | $189.69M(+20.3%) |
| Jun 2013 | - | $157.62M(-5.8%) |
| Mar 2013 | - | $167.24M(-9.1%) |
| Dec 2012 | $609.23M(+21.9%) | $184.03M(+37.9%) |
| Sep 2012 | - | $133.47M(-13.7%) |
| Jun 2012 | - | $154.72M(+11.0%) |
| Mar 2012 | - | $139.37M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $499.83M(+201.5%) | $135.36M(+1.9%) |
| Sep 2011 | - | $132.82M(+12.8%) |
| Jun 2011 | - | $117.70M(+3.7%) |
| Mar 2011 | - | $113.50M(-0.3%) |
| Dec 2010 | $165.76M(-49.0%) | $113.80M(-195.2%) |
| Sep 2010 | - | -$119.58M(-229.4%) |
| Jun 2010 | - | $92.43M(+10.3%) |
| Mar 2010 | - | $83.80M(+1.7%) |
| Dec 2009 | $325.21M(+22.4%) | $82.37M(+10.0%) |
| Sep 2009 | - | $74.90M(-8.1%) |
| Jun 2009 | - | $81.47M(-6.5%) |
| Mar 2009 | - | $87.13M(+16.5%) |
| Dec 2008 | $265.66M(+93.4%) | $74.77M(+4.1%) |
| Sep 2008 | - | $71.82M(+19.0%) |
| Jun 2008 | - | $60.36M(+2.8%) |
| Mar 2008 | - | $58.71M(+38.9%) |
| Dec 2007 | $137.38M(+21.9%) | $42.28M(+39.9%) |
| Sep 2007 | - | $30.22M(-7.7%) |
| Jun 2007 | - | $32.75M(+1.9%) |
| Mar 2007 | - | $32.13M(-0.9%) |
| Dec 2006 | $112.74M(+12.8%) | $32.41M(+1.4%) |
| Sep 2006 | - | $31.96M(+29.0%) |
| Jun 2006 | - | $24.77M(+5.0%) |
| Mar 2006 | - | $23.59M(-3.6%) |
| Dec 2005 | $99.94M(-51.5%) | $24.47M(+6.1%) |
| Sep 2005 | - | $23.05M(-7.7%) |
| Jun 2005 | - | $24.97M(-9.0%) |
| Mar 2005 | - | $27.45M(-71.5%) |
| Dec 2004 | $206.08M(+169.8%) | $96.32M(+224.8%) |
| Sep 2004 | - | $29.66M(-50.7%) |
| Jun 2004 | - | $60.16M(+201.6%) |
| Mar 2004 | - | $19.95M(-22.5%) |
| Dec 2003 | $76.38M(-16.3%) | $25.73M(+20.8%) |
| Sep 2003 | - | $21.29M(+0.4%) |
| Jun 2003 | - | $21.20M(-10.8%) |
| Mar 2003 | - | $23.76M(+5.8%) |
| Dec 2002 | $91.29M(+32.1%) | $22.46M(+9.8%) |
| Sep 2002 | - | $20.46M(+13.7%) |
| Jun 2002 | - | $18.00M(-40.8%) |
| Mar 2002 | - | $30.38M(-18.3%) |
| Dec 2001 | $69.13M(+39.1%) | $37.18M(+151.9%) |
| Sep 2001 | - | $14.76M(-5.6%) |
| Jun 2001 | - | $15.63M(+19.3%) |
| Mar 2001 | - | $13.10M(-3.2%) |
| Dec 2000 | $49.69M(+41.8%) | $13.53M(+23.5%) |
| Sep 2000 | - | $10.96M(+7.7%) |
| Jun 2000 | - | $10.17M(-32.4%) |
| Mar 2000 | - | $15.03M(+32.4%) |
| Dec 1999 | $35.05M(+159.5%) | $11.35M(+17.7%) |
| Sep 1999 | - | $9.64M(+21.4%) |
| Jun 1999 | - | $7.94M(+39.0%) |
| Mar 1999 | - | $5.71M |
| Dec 1998 | $13.50M(+388.8%) | - |
| Dec 1997 | $2.76M | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual total expenses?
- What is the all time high annual total expenses for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual total expenses year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly total expenses?
- What is the all time high quarterly total expenses for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly total expenses year-on-year change?
What is BioMarin Pharmaceutical Inc. annual total expenses?
The current annual total expenses of BMRN is $2.41B
What is the all time high annual total expenses for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual total expenses is $2.41B
What is BioMarin Pharmaceutical Inc. annual total expenses year-on-year change?
Over the past year, BMRN annual total expenses has changed by +$160.58M (+7.13%)
What is BioMarin Pharmaceutical Inc. quarterly total expenses?
The current quarterly total expenses of BMRN is $586.94M
What is the all time high quarterly total expenses for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly total expenses is $719.73M
What is BioMarin Pharmaceutical Inc. quarterly total expenses year-on-year change?
Over the past year, BMRN quarterly total expenses has changed by -$14.54M (-2.42%)